We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Incanthera Plc (INC) ORD GBP0.0002

Sell:15.50p Buy:16.00p Change: 0.02p (0.13%)
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Sell:15.50p
Buy:16.00p
Change: 0.02p (0.13%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Sell:15.50p
Buy:16.00p
Change: 0.02p (0.13%)
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company. The Company's is focused on developing a range of dermatological applications utilizing its unique formulation and delivery technologies to meet the unmet needs in the skincare market. Skin + CELL is the Company’s luxury skincare brand utilizing the advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL's formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.

Contact details

Address:
76 King Street
MANCHESTER
M2 4NH
United Kingdom
Telephone:
+44 (0161) 8175005
Website:
www.incanthera.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

EPIC:
INC
ISIN:
GB00BGL7YW15
Market cap:
£18.12 million
Shares in issue:
92.11 million
Sector:
No specific industry
Exchange:
-
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Timothy Mccarthy
    Executive Chairman
  • Simon Ward
    Chief Executive Officer, Director
  • Laura Brogden
    Chief Financial Officer
  • Suzanne Brocks
    Head of Communications and Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.